Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020
Go back to Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020| Gilead Sciences (NASDAQ: GILD) | Delayed: 143.93 -1.21 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.14 | 52 Week High | $108.63 | |||
| Open | $143.56 | 52 Week Low | $71.39 | |||
| Day High | $144.65 | P/E | 79.52 | |||
| Day Low | $142.77 | EPS | $1.81 | |||
| Volume | 4,921,303 | |||||
